Overexpressing UCP2 accelerated IHC and IHC synapse losses, decreased levels of ATP and MMP levels, and increased ROS production, indicating that overexpressing UCP2 further leads to impairment of IHC and mitochondrial function and disruption of energy homeostasis, which could cause severe hearing loss induced by UCP2 targeting. The gene discussed is UCP2; the disease is hearing loss disorder.